Other Clinical Trial - Stockholm Myocardial Infarction With Nonobstructive

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04681612` - The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA
Recruiting	`NCT04538924` - Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA	N/A
Recruiting	`NCT05198791` - Stratified Medicine of Eplerenone in Acute MI/Injury (StratMed-MINOCA)	Phase 2

See also

Status

Clinical Trial

Phase

Recruiting

NCT04681612 - The Prognostic Role of Indices of Sympathetic Nervous System Overdrive in MINOCA

Recruiting

NCT04538924 - Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA

N/A

Recruiting

NCT05198791 - Stratified Medicine of Eplerenone in Acute MI/Injury (StratMed-MINOCA)

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05426408
Study type	Interventional
Source	Karolinska Institutet
Contact	Per Tornvall, MD
Phone	+468616100
Email	per.tornvall@ki.se
Status	Recruiting
Phase	N/A
Start date	November 1, 2022
Completion date	March 31, 2024

Stockholm Myocardial Infarction With Nonobstructive Coronaries Study 3 — SMINC-3

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms